THROMBOLYTIC AND ANTICOAGULANT THERAPY FOR PULMONARY EMBOLISM WITH HIGH AND INTERMENDIATE RISK OF EARLY DEATH. PART 1. MORTALITY ANDCOMPLICATIONS

Background The advantages of thrombolytic therapy over anticoagulant therapy in the treatment of acute pulmonary embolism are uncertain. Aim of study To compare primary outcomes and incidence of complications in patients with PE of high and intermediate risk in the course of TLT or ACT and to assess...

Descripció completa

Dades bibliogràfiques

Autors principals:	O. V. Nikitina, I. P. Mikhailov, D. A. Kosolapov, V. I. Avfukov, E. A. Ostrogina, S. N. Kuznetsov, T. N. Cherkashina, N. I. Mirda
Format:	Artigo
Idioma:	Russo
Publicat:	Sklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare Department 2018-04-01
Col·lecció:	Неотложная медицинская помощь
Matèries:	pulmonary embolism thrombolytic therapy anticoagulant therapy intermediate risk of adverse outcome mortality rate intracranial hemorrhages cardiac arrhythmias
Accés en línia:	https://www.jnmp.ru/jour/article/view/433
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!